Ultragenyx Pharmaceutical Inc.
Status: Publicly traded
Direct answer
Ultragenyx Pharmaceutical Inc. is publicly traded on NASDAQ under the ticker RARE.
Ultragenyx Pharmaceutical Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing innovative treatments for rare and ultra-rare genetic conditions. Its operations span North America, Europe, and other international markets. The company's portfolio of marketed biologic products addresses several serious diseases. This includes Crysvita (burosumab), an antibody that targets...
Can you invest in Ultragenyx Pharmaceutical Inc.?
Yes. Ultragenyx Pharmaceutical Inc. trades publicly on NASDAQ as RARE.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Ultragenyx Pharmaceutical Inc.
Detailed equity research is provided by MarketSnap.